SE405599B - Forfarande for framstellning av pyridazinoner med terapeutisk verkan - Google Patents

Forfarande for framstellning av pyridazinoner med terapeutisk verkan

Info

Publication number
SE405599B
SE405599B SE7202096A SE209672A SE405599B SE 405599 B SE405599 B SE 405599B SE 7202096 A SE7202096 A SE 7202096A SE 209672 A SE209672 A SE 209672A SE 405599 B SE405599 B SE 405599B
Authority
SE
Sweden
Prior art keywords
pyridazinons
procedure
preparation
therapeutic effect
therapeutic
Prior art date
Application number
SE7202096A
Other languages
English (en)
Swedish (sv)
Inventor
M A Hakim
P T Bysouth
Original Assignee
Bdh Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bdh Pharmaceuticals Ltd filed Critical Bdh Pharmaceuticals Ltd
Publication of SE405599B publication Critical patent/SE405599B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Earth Drilling (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7202096A 1971-02-22 1972-02-21 Forfarande for framstellning av pyridazinoner med terapeutisk verkan SE405599B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB508271A GB1383906A (en) 1971-02-22 1971-02-22 Pyridazinones

Publications (1)

Publication Number Publication Date
SE405599B true SE405599B (sv) 1978-12-18

Family

ID=9789426

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7202096A SE405599B (sv) 1971-02-22 1972-02-21 Forfarande for framstellning av pyridazinoner med terapeutisk verkan

Country Status (15)

Country Link
AT (1) AT313289B (fr)
AU (1) AU465740B2 (fr)
BE (1) BE779390A (fr)
CA (1) CA987322A (fr)
CH (1) CH573921A5 (fr)
DE (1) DE2207517A1 (fr)
ES (1) ES399863A1 (fr)
FR (1) FR2126247B1 (fr)
GB (1) GB1383906A (fr)
IE (1) IE36062B1 (fr)
IL (1) IL38705A (fr)
NL (1) NL7202336A (fr)
NO (1) NO136045C (fr)
SE (1) SE405599B (fr)
ZA (1) ZA72784B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975388A (en) * 1971-02-22 1976-08-17 Bdh Pharmaceuticals Limited Pyridazinones
US4011321A (en) * 1973-12-19 1977-03-08 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting β-adrenergic receptors
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
US4052395A (en) * 1975-09-11 1977-10-04 Sankyo Company Limited Agricultural fungicidal compositions containing 6-(substituted phenyl)-pyridazinones and said pyridazinones
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
DE2854475A1 (de) 1978-12-16 1980-07-03 Basf Ag Neue 3,4-diaza-bicyclo eckige klammer auf 4.1.0 eckige klammer zu hepten-(2)- one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
EP0059688B1 (fr) * 1981-03-04 1985-05-15 Ciba-Geigy Ag Pyridazinones, leur procédé de préparation, compositions pharmaceutiques contenant ces composés et leur utilisation
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3130252A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(5-((omega)-(1-imidazolyl)-alkyl)-thien-2-yl)-3-oxo-2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
EP0101156A3 (fr) * 1982-06-24 1984-08-22 Smith Kline & French Laboratories Limited Procédé pour la préparation de 6-(2-hydroxyphényl)-3-pyridazinone
JPS6153270A (ja) * 1984-08-17 1986-03-17 チバ・ガイギー・アクチエンゲゼルシヤフト 置換ピリダジノン、その製造方法及び該化合物を含む医薬製剤
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
GB8426804D0 (en) * 1984-10-23 1984-11-28 Ciba Geigy Ag Pyridazinones preparations
DE3804490A1 (de) * 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3814057A1 (de) * 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US8835437B2 (en) 2007-06-08 2014-09-16 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
CL2008001671A1 (es) 2007-06-08 2009-07-17 Janssen Pharmaceutica Nv Compuestos derivados de piperidina/piperazina inhibidores de dgat1, composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades metabolicas especialmente diabetes.
CA2687918C (fr) 2007-06-08 2016-11-08 Janssen Pharmaceutica N.V. Derives de piperidine/piperazine
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
EP2296659B1 (fr) 2008-06-05 2016-12-21 Janssen Pharmaceutica, N.V. Combinaisons de médicaments comprenant un inhibiteur de DGAT et un agoniste de PPAR

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670043C3 (de) * 1966-01-07 1975-05-22 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 3-(Aminophenyl)-pyridazon-(6)-derivaten

Also Published As

Publication number Publication date
NO136045B (fr) 1977-04-04
AT313289B (de) 1974-02-11
CA987322A (en) 1976-04-13
FR2126247A1 (fr) 1972-10-06
NL7202336A (fr) 1972-08-24
AU3891172A (en) 1973-08-16
AU465740B2 (en) 1975-10-09
BE779390A (fr) 1972-08-16
CH573921A5 (fr) 1976-03-31
IE36062B1 (en) 1976-08-04
IL38705A (en) 1976-08-31
FR2126247B1 (fr) 1975-08-01
ZA72784B (en) 1972-10-25
IE36062L (en) 1972-08-22
DE2207517A1 (de) 1972-12-14
GB1383906A (en) 1974-02-12
NO136045C (no) 1977-07-13
IL38705A0 (en) 1972-04-27
ES399863A1 (es) 1975-06-16

Similar Documents

Publication Publication Date Title
SE389670B (sv) Forfarande for framstellning av aroyl-substituerade pyrroler med terapeutisk verkan
SE417205B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
FI55988C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE410732B (sv) Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE7507887L (sv) Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan.
SE417206B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan
SE393980B (sv) Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan
SE394430B (sv) Forfarande for framstellning av indolylalkylaminer med terapeutisk verkan
SE385897B (sv) Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner